[Renal lymphoma in a patient after kidney transplantation and cyclosporine therapy].
The effectiveness of renal transplantation has been considerably improved by the use of cyclosporine as an antirejection agent. However, because of those very same immunosuppressive properties, this substance may lead to several infectious or tumoral complications that raise complex therapeutic problems. This article reports about one case of immunoblastic lymphoma discovered in a patient who received renal transplantation and who had been treated with cyclosporine for two years.
Drahy
G
G
Service de Radiologie Centrale, Hôpital de La Pitié, Paris.
Dion
E
E
Faucher
C
C
Bellin
M F
MF
D016572:Cyclosporine / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation; D016400:Lymphoma, Large-Cell, Immunoblastic / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine
Lymphome rénal chez un transplanté traité par ciclosporine.